Compare Entegris Inc (ENTG) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Entegris Inc vs Nuwellis Inc — how do they compare? Entegris Inc trades at $157.37 (market cap $22.95B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Entegris Inc is far larger — about 42280.8× Nuwellis Inc's market cap, and Entegris Inc pays a 0.27% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| ENTG | NUWE | |
|---|---|---|
Market Cap | $22.95B | $542.80K |
Sector | Technology | Technology |
52-Week High | $184.00 | $220.50 |
52-Week Low | $68.80 | $1.42 |
Enterprise Value | $26.16B | -$1.27M |
Dividend Yield | 0.27% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Entegris Inc
Entegris Inc is a supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include Specialty Chemicals & Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The SCEM segment provides high-performance & high-purity process chemistries, gases, & materials, and safe & efficient delivery systems. The Microcontamination Control (MC) segment includes solutions to purify critical liquid chemistries and process gases used in semiconductor manufacturing processes and other high-technology industries. Its geographical segments are Taiwan, North America, South Korea, Japan, China, Europe, and Southeast Asia.
Read more on ENTG →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
